Market Cap

As of July 16, 2010: $38,552,000.00

Stock Chart

CathRx - 30 day Poll

Recent BLOGS About CathRx Add New

There are no blogs to display.

Latest Company News

Website

Videos related to CathRx

Company Profile

Finances:

Originally sponsored by tier 1 Australian Venture Capital firms.

Cash as of 1st December 2010: $5.015M

CathRx’s loss for the half-year ended 31 December 2009 was $5,785,122 compared to a loss of $7,100,918 for the corresponding half-year period ended 31 December 2008.

Sales growth in Europe continued with sales in 2H FY 2010 ($294,408) greater than the whole of FY 2009 ($124,254).


Background:
CathRx Ltd is a specialist Australian medical device company focusing on the development and commercialisation of a range of innovative cardiac catheters for use in the diagnosis and treatment of electrical problems of the heart known as cardiac arrhythmias.

The Company is listed on the Australian Securities Exchange where it is traded under the symbol CXD. It's head office, laboratory and manufacturing facilities are based at Homebush Bay in Sydney. CathRx has appointed numerous distributors in Europe to support the of sales of products which has begun.

Possible outcomes through to June 2010:
 - re-focusing the Company’s sales forecast through expansion into new geographic markets & new products


Terms & Rules

As per ASIC Regulatory Guide 162: All investment tips and comments appearing on this website (Poll results, BLOGS & discussion forums) are submitted by the general public who are not licensed financial advisors. None of the information on this website is financial or investment advice, you should seek independent financial or investment advice by a licensed financial or investment advisor before entering into any position of financial risk. Before using this website, you must agree to the BioInvesting.com.au Terms Of Use

Before using this Biomedical Investing website

OR